Stem cells: the diverging goals of regenerative medicine and oncology ROME JULY 1-2, 2010 CALL FOR ABSTRACTS

12 

Loading....

Loading....

Loading....

Loading....

Loading....

Full text

(1)

CHAIRMEN:

KENNETH R. CHIEN (Boston, USA) GIANLUIGI CONDORELLI (Rome, I)

ROME

JULY 1-2, 2010

Stem cells:

the diverging goals of

regenerative medicine

and oncology

Preliminary Programme

INTERNATIONAL

CONFERENCE

In collaboration with Consiglio Nazionale delle Ricerche Promoted by:

(2)

INTERNATIONAL CONFERENCE

Preliminary

Programme

SCIENTIFIC SECRETARIAT

Fondazione Michelangelo Via Venezian, 1 - 20133 Milan I Phone +39 02 23902397 Fax +39 02 26689997

e-mail: fmichel@istitutotumori.mi.it

Scientific Committee

• Kenneth R. Chien, Director, MGH Cardiovascular Research Center Charles Addison and Elizabeth Ann Sanders, Professor Department of Cell Biology, Harvard Medical School Harvard Stem Cell Institute, Boston USA

• Gianluigi Condorelli, Director of Department of Medicine, National Council of Research (CNR), Rome

• Piero D. Dalerba, Stanford Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, California USA

(3)

OME

JUL

Y

1-2,

2010

• Antonio Baldini, Naples I

• Thomas Brabletz, Freiburg D

• Kenneth R. Chien, Boston USA

• Michael F. Clarke, Stanford USA

• Francesco Cognetti, Rome I

• Gianluigi Condorelli, Rome I

• Giulio Cossu, Milan I

• Maria Grazia Daidone, Milan I

• Michele De Luca, Modena I

• Ruggero De Maria, Rome I

• Frederic J. De Sauvage, San Francisco USA

• Kevin Eggan, Cambridge USA

• Luca Gianni, Milan I

• Gianni Gromo, Basel CH

• Keigo Machida, Los Angeles USA

• Ravindra Majeti, Stanford USA

• Gerry Melino, Rome I

• Christine Mummery, Leiden NL

• Paolo Paoletti, Philadelphia USA

• Pier Giuseppe Pelicci, Milan I

• Lee Rubin, Cambridge USA

• Michael M. Shen, New York USA

• Andreas Trumpp, Heidelberg D

(4)

INTERNATIONAL CONFERENCE

Preliminary

Programme

July 1st,

2010

16.00-19.00

SESSION 1

Opening lectures

Chairmen:K.R. Chien (Boston, USA), G. Condorelli (Rome, I), L. Gianni (Milan, I)

Introductory remarks

K.R. Chien, Boston USA

iPS models of human neurodegenerative diseases

K. Eggan, Cambridge USA

Stem cells and cancer

M.F. Clarke, Stanford USA

(5)

OME JUL Y 1-2, 2010

July 2nd,

2010

09.00-10.00

SESSION 2

Fostering committed maturation

of stem cells

Chairmen:K. Eggan (Cambridge, USA), G. Melino (Rome, I)

Heart progenitors in development and disease

K.R. Chien, Boston USA

Chemical screens to direct reprogramming and differentiation

(6)

INTERNATIONAL CONFERENCE Preliminary Programme

July

2nd

,

2010

10.00-11.00

SESSION 3

Therapeutic applications in regenerative medicine

Chairmen: A. Baldini (Naples, I), M.F. Clarke (Stanford, USA)

Mesangioblast cell therapy for muscular dystrophy

G. Cossu, Milan I

Towards heart regenerative therapy: challenges and opportunities

C. Mummery, Leiden NL 11.00-11.30 Coffee break

11.30-12.30

SESSION 3

Therapeutic applications in regenerative medicine

Chairmen: A. Baldini (Naples, I), M.F. Clarke (Stanford, USA)

Stem cells for corneal tissue repair and genetic skin disorders:

clinical challenges

M. De Luca, Modena I

Stem cells and drug discovery: the road ahead

G. Gromo, Basel CH 12.30-13.30 Lunch

(7)

Stem cells: the diverging goals of regenerative medicine and oncology

OME JUL Y 1-2, 2010

July

2nd

,

2010

13.30-15.30

SESSION 4

Modelling cancer as a stem cells disease

Chairmen:F. Cognetti (Rome, I), R. De Maria (Rome, I)

Breast cancer initiating cells as drivers of disease and markers

of prognosis

P.G. Pelicci, Milan I

Luminal epithelial origin of prostate cancer stem cells

M.M. Shen, New York USA

Stem cells of hepatocarcinoma

K. Machida, Los Angeles USA

microRNAs, EMT and cancer stem cells

T. Brabletz, Freiburg D 15.30-16.00 Coffee break

(8)

INTERNATIONAL CONFERENCE

Preliminary

Programme

16.00-17.30

SESSION 5

Therapeutic applications in oncology

Chairmen:M.G. Daidone (Milan, I), P. Paoletti (Philadelphia, USA)

Monoclonal antibody targeting of cancer stem cells

R. Majeti, Stanford USA

Shh pathway inhibitors for the treatment of basal cell carcinoma

and medulloblastoma

F.J. De Sauvage, San Francisco USA

Therapeutic implications of awakening quiescent cancer

stem cells

A.Trumpp, Heidelberg D

17.30-18.00

Closing remarks

K.R. Chien(Boston, USA),G. Condorelli(Rome, I),L. Gianni(Milan, I)

July

2nd

,

(9)

OME

JUL

Y

1-2,

2010

Conference General Information

Conference Venue

CNR, Consiglio Nazionale delle Ricerche P.le Aldo Moro, 7 - 00185 Rome, I

Dates of the Conference

From Thursday July 1st to Friday July 2nd, 2010

CME accreditation

Applications to the competent bodies will be made to obtain appro-val for CME:

• EACCME for European and American (AMA) CME accreditation

• Royal College of Physicians for British CME accreditation

• Italian CME accreditation for Physicians and non-Physicians

Visa application - Letter of invitation

EU citizens require only passport or national identity card to stay in Italy. Participants from other countries are advised to contact their nearest Italian Embassy or Consulate regarding Visa rules and regulations. Upon request, the Chairmen of the Conference will be happy to send a personal letter of invitation to enable participants to obtain support for Visa to attend the Conference.

This announcement cannot be considered as an offer of financial support.

Call for abstracts

Deadline for receipt: June 11, 2010 DEADLINE WILL NOT BE EXTENDED.

Abstracts will only be submitted through the electronic abstract form on the web site at: www.makevent.it

Registration Fee

(Registration fee are VAT included)

• Physicians 360,00 euro

• Up to 35 years old 120,00 euro

Registration fee includes: Participation to all scientific sessions, con-gress material, coffee breaks, snack lunch and CME credits

Cancellation and refund

Refund of fee (by written request) with 30% administrative charge de-duction, can be applied for until June 15th, 2010. After June 16th, 2010 no refund.

Organizing Secretariat

Effetti srl

Via Gallarate, 106 - 20151 Milan I

Phone +39 02 3343281 - Fax +39 02 38006761 e-mail: michelangelo@effetti.it

(10)

R OME JUL Y 1-2, 2010

Application form

Stem cells: the diverging goals of regenerative medicine and oncology

Title: ❍Dr ❍Prof. ❍Mr ❍Ms

Family Name _____________________________________________________________________________________________________________________________________________________ First Name________________________________________________________________________________________________________________________________________________________ Company/Institute_________________________________________________________________________________________________________________________________________________ Mailing address___________________________________________________________________________________________________________________________________________________ Postal Code________________________________________ City ________________________________________________________________________________________________________ Country __________________________________________________________________________________________________________________________________________________________ Phone ____________________________________________________________ Fax__________________________________________________________________________________________ e-mail ____________________________________________________________________________________________________________________________________________________________

PHYSICIAN ❍360,00€ UP TO 35 YEARS OLD ❍120,00€

Payment details

All payment should be in euro and made out to Effetti srl.

Methods of payment

BANK TRANSFER

To Effetti srl - Intesa San Paolo, Ag. 4048 - Via Ripamonti, Milan IBAN: IT68 P 03069 09545 100000000337

Please send a copy of your transfer order with this application form to Effetti srl (Via Gallarate 106 - 20151 Milan, Italy).

CREDIT CARD

❍Visa ❍Eurocard/Mastercard

Credit card no  Expiry date____________

I already authorized Effetti to debit my credit card for the total registration fee due: € ______________________________

(11)

JUL

Y

1-2,

2010

PRIVACY LAW

IN ACCORDANCE WITH ARTICLE 23, ITALIAN LAW 196/03

I give my consent to the treatment and communication of my personal data, and to re-lated usage methods and destination, to subjects performing activities as indicated in said information. I am aware that, by failing to give my consent, registration cannot be completed.

Signature ____________________________________________________________________

IN ACCORDANCE WITH ARTICLE 7, ITALIAN LAW 196/03

I also give my consent for the data provided by myself to be used for the issue of in-formation and commercial offers, also by third parties, and of advertising and infor-mational material, for the completion of market research studies and the processing of commercial statistics. I am aware that, by failing to give my consent, registration can-not be completed.

Signature

IN ACCORDANCE TO ARTICLES 42 AND 43, ITALIAN LAW 196/2003

Lastly, I give my consent for data provided by myself to be transferred to associate, controlled or other companies with commercial relations with Effetti S.r.l., also outside European Union territory. I am aware that, by failing to give my consent, registration cannot be completed.

Signature ____________________________________________________________________

To be sent to:

Effetti srl - Via Gallarate 106 - 20151 Milan, I

fax:+39 02 38006761

(12)

Figure

Updating...

References

Updating...

Related subjects :